U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 2021 - 2030 of 24164 results

Status:
Investigational
Source:
INN:bifluranol [INN]
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Bifluranol (brand name Prostarex), a fluorinated bibenzyl anti-androgen was developed as a nonsteroidal estrogen and was studied for the treatment of benign prostatic hyperplasia. Besides, was shown that bifluranol inhibited 17 alpha-hydroxylase/C17-C20 lyase.
Status:
Investigational
Source:
INN:bentiamine [INN]
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Bentiamine (also known as dibenzoyl thiamine), a derivative of thiamine, is rapidly absorbed and converted to thiamine. Experiments on rodent have shown that this compound had low toxicity and absence of carcinogenicity.
Status:
Investigational
Source:
NCT03388788: Early Phase 1 Interventional Completed Cardiovascular Risk Factor
(2018)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Investigational
Source:
INN:panadiplon
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Panadiplon (previously known as U-78875) was investigated as a compound with a high affinity for the benzodiazepine receptors. It was studied as a unique anxiolytic agent with a minimum of central nervous system depression for the treatment of anxiety disorders. However, panadiplon was dropped from clinical development due to unexpected hepatic toxicity in human volunteers. It was shown that the drug-induced mitochondrial dysfunction in the liver, and suggested that this dysfunction could be attributed to the carboxylic acid metabolite.
Status:
Investigational
Source:
INN:rolafagrel
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Rolafagrel (FCE 22178) is a selective thromboxane synthase inhibitor that has been evaluated for use in the treatment of diabetic nephropathy and thrombosis. Rolafagrel inhibits platelet and glomerular thromoxane synthase in animal and human kidney disease. A phase I clinical trial did not report drug-related adverse events. No information is available on current use of rolafagrel.
Status:
Investigational
Source:
NCT02441595: Not Applicable Interventional Completed Parent-Child Relations
(2015)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Carbendazim is a broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities widely used as a fungicide in agriculture and home gardening, and as an antihelminthic in veterinary medicine. As a fungicide, carbendazim used for controls Ascomycetes, Fungi Imperfecti, and Basidiomycetes on a wide variety of crops, including bananas, cereals, cotton, fruits, grapes, mushrooms, ornamentals, peanuts, sugarbeet, soybeans, tobacco, and vegetables. Carbendazim is a chemically stable and relatively persistent fungicide which only metabolizes to a limited extent in plants and in soil. The only detected metabolite is 2-aminobenzimidazole, which constitutes less than 5% of the total residues in leaves. Carbendazim may be anticipated to metabolize in the animal into hydroxylated analogues which may appear in meat and milk products. Carbendazim acts as a mitotic poison by altering tubulin binding and microtubule formation. This has been proposed as a possible mechanism of action for the developmental abnormalities seen in animal studies with high concentrations.
Status:
Investigational
Source:
INN:prefenamate
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Prefenamate is an esters of N-substituted anthranilic acid patented by Ferrer Internacional S. A. as antiinflammatory agent
Status:
Investigational
Source:
INN:enciprazine [INN]
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Enciprazine also known as WY-48624 or, D-3112 is a GABA A receptor agonist which was in the phase III of clinical trial for the treatment of anxiety disorders. Enciprazine was well tolerated, with low levels of sedative and asthenic side effects reported. However, research was discontinued.
Status:
Investigational
Source:
INN:alemcinal
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Alemcinal (ABT-229), a 12-deoxymotilide, is a potent motilin agonist stereoselectively designed by Abbott researchers as an orally active gastroprokinetic agent. ABT-229 is selective agonist of the motilin receptor. ABT-229 is a synthetic derivative of erythromycin with no antibiotic activity, it has been shown to bind to motilin receptors and stimulate contractile activity of the antrum and small intestine. However, the development of Alemcinal was discontinued.
Status:
Investigational
Source:
NCT00001933: Phase 2 Interventional Completed Alzheimer's Disease
(1999)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)



Nefiracetam is a cyclic derivative of gamma-aminobutyric acid (GABA). It is thought to act by normalising dysfunctional acetylcholine, GABA and possibly monoamine neurotransmitter systems, but it may also facilitate N/L-type calcium channel opening. Nefiracetam has received attention as a treatment for seizures, depression, and dementia. Nefiracetam was found to be extremely testicular toxic in both rats and dogs; it was found to significantly decrease the levels of testicular testosterone leading to atrophy and malformation of sperm.

Showing 2021 - 2030 of 24164 results